Comparison of incident hypertension between SGLT2 inhibitors vs. DPP4 inhibitors
Comparison of incident hypertension between SGLT2 inhibitors vs. DPP4 inhibitors
About this item
Full title
Author / Creator
Publisher
England: Nature Publishing Group
Journal title
Language
English
Formats
Publication information
Publisher
England: Nature Publishing Group
Subjects
More information
Scope and Contents
Contents
Although several randomized clinical trials have reported the potential benefit of sodium-glucose cotransporter 2 inhibitors (SGLT2i) in reducing blood pressure (BP), whether SGLT2i can reduce incident hypertension is unknown. We analyzed individuals with diabetes who were newly prescribed SGLT2i or dipeptidyl peptidase 4 inhibitors (DPP4i) in a la...
Alternative Titles
Full title
Comparison of incident hypertension between SGLT2 inhibitors vs. DPP4 inhibitors
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11224012
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11224012
Other Identifiers
ISSN
0916-9636,1348-4214
E-ISSN
1348-4214
DOI
10.1038/s41440-024-01649-z
